Source: http://www.google.com/patents/US7503931?dq=6,418,462
Timestamp: 2017-03-30 14:00:02
Document Index: 674171768

Matched Legal Cases: ['§ 121', 'art 10', 'art 10', 'art 10', 'art 10', 'art 10']

Patent US7503931 - System and method to effect the mitral valve annulus of a heart - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn assembly for effecting the condition of a mitral valve annulus includes a mitral valve therapy device, a coupling structure carried by the device, a catheter, a second coupling structure, and a locking member. To implant the device, the device is first releasably locked to a pushing member by the...http://www.google.com/patents/US7503931?utm_source=gb-gplus-sharePatent US7503931 - System and method to effect the mitral valve annulus of a heartAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS7503931 B2Publication typeGrantApplication numberUS 11/234,809Publication dateMar 17, 2009Filing dateSep 23, 2005Priority dateDec 26, 2002Fee statusPaidAlso published asUS6793673, US6964683, US20040127980, US20040243228, US20060020335, WO2004060217A1, WO2004060217A9Publication number11234809, 234809, US 7503931 B2, US 7503931B2, US-B2-7503931, US7503931 B2, US7503931B2InventorsLeonard Kowalsky, Gregory D. Nieminen, Ryan H. Braxtan, Mark L. MathisOriginal AssigneeCardiac Dimensions, Inc.Export CitationBiBTeX, EndNote, RefManPatent Citations (100), Non-Patent Citations (13), Referenced by (44), Classifications (5), Legal Events (4) External Links: USPTO, USPTO Assignment, EspacenetSystem and method to effect the mitral valve annulus of a heart
US 7503931 B2Abstract
An assembly for effecting the condition of a mitral valve annulus includes a mitral valve therapy device, a coupling structure carried by the device, a catheter, a second coupling structure, and a locking member. To implant the device, the device is first releasably locked to a pushing member by the coupling structures and the locking member. When the device is positioned within the coronary sinus adjacent the mitral valve annulus and deployed, the coupling structures may be released from each other by the release of the locking member.
1. A method of delivering a mitral valve therapy device into the heart, the method comprising:
providing a therapy device comprising a first coupling structure;
providing a delivery device with a second coupling structure;
releasably locking the first and second coupling structures by passing a locking member through at least one of the first and second coupling structures;
delivering the therapy device and the delivery device through a delivery catheter; and
deploying the therapy device from the delivery catheter and into the coronary sinus.
2. The method of claim 1 further comprising withdrawing the locking member to release the first coupling structure from the second coupling structure.
3. The method of claim 2 wherein withdrawing the locking member comprises proximally withdrawing the locking member to release the first coupling structure from the second coupling structure.
4. The method of claim 1 wherein passing a locking member through at least one of the first and second coupling structures comprises passing a pin through at least one of the first and second coupling structures.
5. The method of claim 1 wherein the releasably locking step comprises passing the locking member through the first and second coupling structures.
6. The method of claim 1 wherein the first coupling structure forms a loop.
7. The method of claim 1 wherein the first coupling structure is disposed at a proximal end of the therapy device.
8. The method of claim 1 wherein the second coupling structure is disposed at a distal end of the delivery device.
9. A system to deliver a therapy device into the coronary sinus to treat mitral valve regurgitation, comprising:
a therapy device adapted to be delivered into a coronary sinus, the therapy device comprising a first coupling structure;
a delivery device comprising a second coupling structure;
a locking member that releasably locks the first and second coupling structures, wherein the locking member passes through at least one of the first and second coupling structures to lock the first and second coupling structures; and
a delivery catheter adapted to deliver the therapy device into the coronary sinus.
10. The system of claim 9 wherein the first coupling structure is disposed at a proximal end of the therapy device.
11. The system of claim 9 wherein the second coupling structure is disposed at a distal end of the delivery device.
12. The system of claim 9 wherein the locking member passes through the first and second coupling structures to lock the first and second coupling structures.
13. The system of claim 9 wherein the first coupling structure comprises a loop.
14. The system of claim 9 wherein the second coupling structure comprises a loop. Description
This application is a continuation application of Ser. No. 10/798,728, filed Mar. 10, 2004 now U.S. Pat. No 6,964,683, which is a divisional application of Ser. No. 10/331,143, filed Dec. 26, 2002 now U.S. Pat. No. 6,793,673, which is incorporated herein by reference in its entirety, and to which application we claim priority under 35 U.S.C. § 121.
The present invention generally relates to a system and method to effect the mitral valve annulus of a heart. The present invention more particularly relates to a mitral valve annulus device, system, and method wherein the device is deployed and anchored in the coronary sinus of a heart adjacent the mitral valve annulus to reshape the mitral valve annulus.
The human heart generally includes four valves. Of these valves, a most critical one is known as the mitral valve. The mitral valve is located in the left atrial ventricular opening between the left atrium and left ventricle. The mitral valve is intended to prevent regurgitation of blood from the left ventricle into the left atrium when the left ventrical contracts. In preventing blood regurgitation the mitral valve must be able to withstand considerable back pressure as the left ventricle contracts.
The valve cusps of the mitral valve are anchored to muscular wall of the heart by delicate but strong fibrous cords in order to support the cusps during left ventricular contraction. In a healthy mitral valve, the geometry of the mital valve ensures that the cusps overlie each other to preclude regurgitation of the blood during left ventricular contraction.
While the prior art methods mentioned above have been able to achieve some success in treating mitral regurgitation, they have not been without problems and potential adverse consequences. For example, these procedures require open heart surgery. Such procedures are expensive, are extremely invasive requiring considerable recovery time, and pose the concomitant mortality risks associated with such procedures. Moreover, such open heart procedures are particularly stressful on patients with a compromised cardiac condition. Given these factors, such procedures are often reserved as a last resort and hence are employed late in the mitral regurgitation progression. Further, the effectiveness of such procedures is difficult to assess during the procedure and may not be known until a much later time. Hence, the ability to make adjustments to or changes in the prostheses to obtain optimum effectiveness is extremely limited. Later corrections, if made at all, require still another open heart surgery.
The device includes an elongated flexible member having a cross sectional dimension for being received within the coronary sinus of the heart. The device includes an anchor at each of its ends. When placed in the coronary sinus, anchored and drawn taught, the device exerts an inward pressure on the mitral valve. The inward pressure increases the radius of curvature of the mitral valve annulus, or at least a portion of it, to promote effective valve sealing action and eliminate mitral regurgitation.
The device may be implanted in the coronary sinus using only percutaneous techniques similar to the techniques used to implant cardiac leads such as pacemaker leads. One prior proposed system for implanting the device includes an elongated introducer configured for being releasably coupled to the device. The introducer is preferably flexible to permit it to advance the device into the heart and into the coronary sinus through the coronary sinus ostium. To promote guidance, an elongated sheath is first advanced into the coronary sinus. Then, the device and introducer are moved through a lumen of the sheath until the device is in position within the coronary sinus. Because the device is formed of flexible material, it conforms to the curvatures of the lumen as it is advanced through the sheath. The sheath is then partially retracted. The distal end of the device is then anchored. Then, the sheath is retracted proximally past the proximal end of the device. The introducer is then drawn proximally to place the device in tension, where upon the proximal anchor is set. The procedure is then completed by the release of the introducer from the device and retraction of the introducer and sheath. As a result, the device is left within the coronary sinus to exert the inward pressure on the mitral valve annulus.
While the foregoing represents great adjunctment in the art, further improvement is possible. For example, in the prior delivery system, described hereinbefore, release of the introducer from the device is difficult. The device and introducer carried interlocking couplers which required an uncoupling action to be applied to the introducer to unlock the device from the introducer. This action could cause the device position to change and adversarily alter its effectiveness. Still further, neither the device nor the introducer were well suited for recapturing the device for removal. Recapture and removal of the device may be advisable if exchange to a device of different dimension is considered to be more appropriate for a given patient.
Hence, there is a need for a more effective device, delivery assembly, and method to deliver a mitral valve annulus therapy device into the coronary sinus adjacent the mitral valve annulus and to release the device in a manner which leaves the device positioning unaffected. Still further, there is a need for such a device and assembly which provides recapture of the device should such recapture be required for removal of the device. The present invention addresses these needs.
The invention provides an assembly for effecting the condition of a mitral valve annulus of a heart. The assembly includes a mitral valve therapy device that reshapes the mitral valve annulus of the heart when placed within the coronary sinus of the heart adjacent the mitral valve annulus. The mitral valve therapy device has a proximal end including a coupling structure. The assembly further includes a catheter having a lumen that directs the mitral valve therapy device into the coronary sinus of the heart, a second coupling structure that is lockable on the device coupling structure, and a locking member that locks the device coupling structure to the second coupling structure and that releases the device coupling structure from the second coupling structure.
The assembly may further include a pusher member that pushes the device through the catheter lumen. The pusher member has a distal end that engages the device proximal end. The pusher member may carry the second coupling structure at the distal end of the pusher member.
The device coupling structure may comprise a hoop structure. The second coupling structure may also comprise a hoop structure. The locking member comprises a pin that extends through the hoop structures to lock the coupling structures together and that is retractable to release the hoop structures. The catheter has a distal end and the pin is preferably long enough to extend through the distal end of the catheter. The pusher member may be an elongated coil.
The device coupling structure and the second coupling structure may alternatively comprise a pair of interlocking structures and the locking member may comprise a slide-lock sheath closely fitted to the interlocking structures. The interlocking structures and the slide-lock sheath may be tubular. The pusher member has a distal end that engages the device proximal end, and carries the second coupling structure. The locking member may further include a tether that extends from the slide-lock sheath to and through the catheter lumen to permit the tether to pull proximally on the slide-lock sheath for releasing the interlocking structures.
The assembly may further include a retractor configured to extend through the catheter lumen and grip the device coupler. This permits retraction of the device through the catheter.
The invention further provides an assembly for effecting the condition of a mitral valve annulus of a heart comprising device means for reshaping the mitral valve annulus of the heart when placed within the coronary sinus of the heart adjacent the mitral valve annulus. The device means has a proximal end including a coupling means for coupling the device means. The assembly further comprises catheter means having a lumen that directs the mitral valve therapy device into the coronary sinus of the heart, second coupling means for locking with the device coupling means, and locking means for locking the device coupling means to the second coupling means and releasing the device coupling means from the second coupling means.
The present invention further provides a method of implanting a mitral valve therapy device to effect the condition of a mitral valve annulus of a heart. The method includes the steps of feeding a catheter having a lumen into the coronary sinus of the heart, locking the device to a deployment member with a locking member, and directing the mitral valve therapy device through the catheter lumen into the coronary sinus with the deployment member. The method further includes the steps of positioning the mitral valve therapy device in the coronary sinus with the deployment member, releasing the locking member from the device and the deployment member coupler, removing the deployment member and the locking member from the catheter lumen, and removing the catheter from the coronary sinus.
The invention still further provides a method of effecting the condition of a mitral valve annulus of a heart. The method includes the steps of feeding a catheter having a lumen into the coronary sinus of the heart, aligning a mitral valve therapy device coupler of a mitral valve therapy device to a deployment member coupler, and locking the device coupler to the deployment member coupler with a locking member. The method further includes directing the mitral valve therapy device through the catheter lumen into the coronary sinus with the deployment member, positioning the mitral valve therapy device in the coronary sinus with the deployment member, releasing the locking member from the device coupler and the deployment member coupler, removing the deployment member, the deployment member coupler and the locking member from the catheter lumen, and removing the catheter from the coronary sinus.
The invention further provides an assembly for effecting the condition of a mitral valve annulus of a heart which includes a mitral valve therapy device that reshapes the mitral valve annulus of the heart when placed within the coronary sinus of the heart adjacent the mitral valve annulus, the mitral valve therapy device having a proximal end including a coupling structure and a guide member that directs the mitral valve therapy device into the coronary sinus of the heart. The assembly further includes a second coupling structure that is lockable on the device coupling structure, and a locking member that locks the device coupling structure to the second coupling structure and that releases the device coupling structure from the second coupling structure.
The invention further provides an assembly for effecting the condition of a mitral valve annulus of a heart. The assembly includes device means for reshaping the mitral valve annulus of the heart when placed within the coronary sinus of the heart adjacent the mitral valve annulus, the device means having a proximal end including a coupling means for coupling the device means, guide means for directing the mitral valve therapy device into the coronary sinus of the heart, second coupling means for locking with the device coupling means, and locking means for locking the device coupling means to the second coupling means and releasing the device coupling means from the second coupling means.
The invention still further provides a method of implanting a mitral valve therapy device to effect the condition of a mitral valve annulus of a heart. The method includes the steps of feeding a guide member into the coronary sinus of the heart, locking the device to a deployment member with a locking member, directing the mitral valve therapy device along the guide member into the coronary sinus with the deployment member, positioning the mitral valve therapy device in the coronary sinus with the deployment member, releasing the locking member from the device and the deployment member coupler, and removing the deployment member, the locking member, and the guide member from the coronary sinus.
FIG. 2 is a superior view of a human heart similar to FIG. 1 illustrating a mitral valve therapy device embodying the present invention deployed therein and which may be by deployed an assembly embodying the present invention;
FIG. 3 is a superior view similar to FIG. 1 with portions cut away illustrating the device of FIG. 2 being deployed by a deployment assembly embodying the present invention;
FIG. 4 is a partial perspective view to an enlarged scale illustrating the coupling members and locking member of a first embodiment of the present invention;
FIG. 5 is a view similar to FIG. 4 illustrating the release of the coupling structures;
FIG. 6 is a superior view similar to FIG. 1 illustrating recapture of the deployed device;
FIG. 7 is a partial perspective view to an enlarged scale illustrating the recapture of the device;
FIG. 8 is a superior view similar to FIG. 1 illustrating a further embodiment of the present invention;.
FIG. 9 is a partial perspective view of the coupling and locking arrangement of FIG. 8; and
FIG. 10 is a partial perspective view illustrating the release of the coupling members of FIG. 8.
Referring now to FIG. 1, it is a superior view of a human heart 10 with the atria removed to expose the mitral valve 12, and the coronary sinus 14 of the heart 10. Also generally shown in FIG. 1 are the pulmonary valve 22, the aortic valve 24, and the tricuspid valve 26 of the heart 10.
The mitral valve 12 includes an anterior cusp 16, a posterior cusp 18 and an annulus 20. The annulus encircles the cusps 16 and 18 and maintains their spacing to provide a complete closure during a left ventricular contraction. As is well known, the coronary sinus 14 partially encircles the mitral valve 12 adjacent to the mitral valve annulus 20. As is also known, the coronary sinus is part of the venus system of the heart and extends along the AV groove between the left atrium and the left ventricle. This places the coronary sinus essentially within the same plane as the mitral valve annulus making the coronary sinus available for placement of the mitral valve therapy device of the present invention therein.
FIG. 2 shows a mitral valve therapy device 30 embodying the present invention shown deployed in the coronary sinus 14 of the heart 10 adjacent the mitral valve annulus 20 for effecting the geometry of the mitral valve annulus. The device 30 takes the form of an elongated body 32 which includes a distal anchor 34 and a proximal anchor 36.
The anchors 34 and 36 are shown in FIG. 2 in their deployed configuration. A more complete description of the anchors 34 and 36 may be had in copending application Ser. No. 10/142,637, filed May 8, 2002 for BODY LUMEN DEVICE ANCHOR, DEVICE AND ASSEMBLY which is assigned to the assignee of the present invention and hereby incorporated herein by reference. In deploying the device 30 in the coronary sinus, the distal anchor 34 is first deployed to anchor the distal end of the device 30. In the anchoring process, the anchor 34 is expanded outwardly to anchor the device in the coronary sinus against both bi-directional longitudinal and rotational movement. This allows the device 30 to be tightened within the coronary sinus by pulling of the device's proximal end. Then, the proximal anchor 36 is deployed. The device 30, which may be formed from Nitinol or stainless steel, for example, now exerts an inward pressure on the mitral valve annulus 20 to advantageously effect its geometry.
The device 30 along with its deployment system 50 is illustrated in FIG. 3. As shown, the device is in the process of being implanted in the coronary sinus 14 of the heart 10. Its proximal anchor 36 and distal anchor 34 have yet been deployed. The deployment system 50 includes an elongated catheter 52, an elongated pusher 54, a coupling structural member 56 and a locking pin 58. As may be noted in FIG. 4, the proximal end of the device 30 includes a coupling loop 38. The pusher 54 is preferably an elongated coil having a center lumen 55. The coupling member 56 is formed from a cable that is provided with a loop 57. The legs or ends 59 of the loop 57 extend proximally through the lumen 55 and out the proximal end of the pusher 54.
The locking pin 58 also extends proximally out of the proximal end of the pusher 54. As shown in FIG. 4, the coupling loops 38 and 57 are aligned to overlap and the locking pin 58 is extended through the overlapping loops. This causes the device 30 to be releasably locked to the pusher 54.
In deploying the device 30, the catheter 52 is first fed into the coronary sinus 14 adjacent the mitral valve annulus 20. The device 30 and pusher 54 are then releasably locked together as shown in FIG. 4. The device is then loaded into the catheter 52. The pusher 54 follows the device into the catheter 52 and is then advanced along the catheter to push the device 30 distally down the catheter to a predetermined position adjacent the mitral valve annulus 14 at the distal end of the catheter 52. Thereafter, the device is maintained in a stationary position by the pusher 54 as the catheter 52 is partially withdrawn to expose the distal anchor 34. Once the distal anchor 34 is exposed, it is deployed in a manner as fully described in the aforementioned copending application Ser. No. 10/142,637. Once the distal anchor 34 is deployed, the catheter 50 is then retracted proximally of the proximal anchor 36. This exposes the proximal anchor 36. Once the proximal anchor is exposed, the pusher 54 is pulled proximally for tightening the device within the coronary sinus and to an extent which results in the desired effect on the geometry of the mitral valve annulus 20. During this adjustment process, mitral regurgitation may be monitored and the device adjusted for optimal results. When the device 30 is in its final position within the coronary sinus 14, the proximal anchor 36 may then be deployed. The beneficial effect of the device may now again be evaluated. Once the device is ready for chronic implant, the locking pin 58 may be pulled proximally from the proximal end of the pusher 54 as shown in FIG. 5 to disengage the coupling members 38 and 56. With the pusher 54 now free from the device 30, the pusher 54, catheter 52, coupling member 56 and locking pin 58 may then be removed from the heart.
As can be appreciated by those skilled in the art, guide members, other than a guide catheter as shown herein, may be used to direct the device into the coronary sinus. For example, a guide wire, of the type well known in the art may alternatively be employed to guide the device there along into the coronary sinus without departing from the present invention.
FIGS. 6 and 7 illustrate the manner in which the device 30 may be removed from the coronary sinus 14 if necessary in accordance with further aspects of the present invention. As may be seen in FIGS. 6 and 7, the device 30 may be removed from the coronary sinus 14 with a retractor assembly 60. The retractor assembly includes the catheter 62, and a retractor 64 comprising an elongated coil 65 and a coupling member 66. The elongated coil 65 of the retractor 64 is essentially identical to the pusher 54 as illustrated in FIGS. 3-5. The coupling member 66 may be a cable which extends down the center lumen of the elongated coil 65 to form a loop structure 66 and which then returns through the center lumen of the elongated coil 65 such that the free ends 69 of the cable 63 extend out the proximal end of the elongated coil 65. As also seen in FIGS. 6 and 7, if the device 30 is to be removed from the coronary sinus 14, the cable 63 is threaded into the elongated coil 65 to form the loop structure 66. With the retractor 64 thus formed, the retractor is then guided down the catheter 62 to the proximal end of the device 30 and more specifically to the coupling loop member 38 of the device 30. The loop 66 of the cable 63 is then wrapped about the loop coupling member 38 of the device 30 and the free ends 69 of the cable are drawn proximally to tighten the loop structure 66 about the loop coupling member 38. The retractor 64 now has a grip on the device 30. With the device 30 now being firmly held by the retractor 64, the retractor 64 may be pulled proximally within the catheter 62 to impart proximal movement to the device 30. When the anchors 34 and 36 of the device 30 engage the distal end of the catheter 62, they will be collapsed to disengage from the coronary sinus. The device may now be removed by pulling on the retractor 64 proximally within the catheter 62 until the device is fully removed from the heart and the patient. Alternatively, the device may be drawn into the catheter. The catheter and the device may then be withdrawn together from the patient.
FIGS. 8-10 illustrate a further embodiment of the present invention for releasably locking a pusher member to a mitral valve therapy device for implanting the mitral valve therapy device adjacent the mitral valve annulus within the coronary sinus of the heart.
As illustrated in FIG. 8, the mitral valve therapy device 70 is elongated and includes a distal anchor 74 and a proximal anchor 76. The anchors are not yet deployed. The device 70 further includes, at its proximal end, a coupling structure 78.
For deploying the device 70, a deployment system 90 is also illustrated. The deployment system includes a catheter 92, a pusher member 94, a coupling structure 96 at the distal end of the pusher 94, and a locking member 98. As will be best seen in FIG. 9, the coupling member 78 of the device 70 and the coupling member 96 of the pusher 94 form a pair of interlocking structures. The coupling structures 78 and 96 are tubular and the locking member 98 is also tubular.
When it is desired to implant the device 70, the device 70 is coupled to the pusher 98 by the interlocking structures of the coupling members 78 and 96 which are held together and in place by the locking member 98. Then, as previously described in the previous embodiment, the device and pusher member are fed down the catheter 92 until the device reaches a desired position within the coronary sinus adjacent the mitral valve annulus 20. Once in this position, the device is held stationary by the pusher member 94 while the catheter 92 is retracted to expose the distal anchor 74. The distal anchor 74 may now be deployed in a manner as described in the aforementioned copending application Ser. No. 10/142,637. With the distal anchor 74 deployed, the catheter 92 is then retracted until it is proximal to the proximal anchor 76. The pusher 94 may then be pulled to tighten the device within the coronary sinus. Once the device 70 has been tightened to a desired degree, as confirmed by device effectiveness evaluation, the device 70 is ready for chronic implant.
When the device 70 is to be left within the coronary sinus 14, the tether 99 is pulled to slide the locking member 98 off of the interlocking structures 78 and 96. The coupling structures of the pusher 94 may be prestressed for disengaging the coupling structure 78 of the device 70 when the locking member 98 is pulled proximal to the interlocking structures. The device 70 is now free from the pusher member 94. The pusher member 94 together with the tether, locking member, and catheter 92 may be removed from the heart. With the implant of the device 70 completed, the device 70 is left within the coronary sinus adjacent the mitral valve annulus 20 to treat the mitral valve such as by eliminating mitral regurgitation.
As illustrated in FIG. 10, the coupling structure 96 is prestressed to deflect outwardly when the tubular locking member 98 is pulled proximally to disengage the device 70 from the pusher 94. Alternatively, the coupling structure 96 may be prestressed inwardly with a locking pin (not shown) extending into coupling stricture 78 to maintain the locked arrangement. Here, proximal pulling of the pin would cause the coupling structure 96 to deflect inwardly to disengage the coupling structure 78 and 96.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3974526Jan 23, 1975Aug 17, 1976Dardik Irving IVascular prostheses and process for producing the sameUS3995623Feb 11, 1976Dec 7, 1976American Hospital Supply CorporationMultipurpose flow-directed catheterUS4055861Apr 9, 1976Nov 1, 1977Rhone-Poulenc IndustriesSupport for a natural human heart valveUS4164046May 16, 1977Aug 14, 1979Cooley DentonValve prosthesisUS4485816Jun 25, 1981Dec 4, 1984AlchemiaShape-memory surgical staple apparatus and method for use in surgical suturingUS4550870Oct 13, 1983Nov 5, 1985Alchemia Ltd. PartnershipStapling deviceUS4588395Oct 28, 1980May 13, 1986Lemelson Jerome HCatheter and methodUS4830023Nov 27, 1987May 16, 1989Medi-Tech, IncorporatedMedical guidewireUS5061277Sep 2, 1988Oct 29, 1991Baxter International Inc.Flexible cardiac valvular support prosthesisUS5099838Dec 15, 1988Mar 31, 1992Medtronic, Inc.Endocardial defibrillation electrode systemUS5250071Sep 22, 1992Oct 5, 1993Target Therapeutics, Inc.Detachable embolic coil assembly using interlocking clasps and method of useUS5261916Dec 12, 1991Nov 16, 1993Target TherapeuticsDetachable pusher-vasoocclusive coil assembly with interlocking ball and keyway couplingUS5265601May 1, 1992Nov 30, 1993Medtronic, Inc.Dual chamber cardiac pacing from a single electrodeUS5350420May 25, 1993Sep 27, 1994Baxter International Inc.Flexible annuloplasty ring and holderUS5433727Aug 16, 1994Jul 18, 1995Sideris; Eleftherios B.Centering buttoned device for the occlusion of large defects for occludingUS5441515Apr 23, 1993Aug 15, 1995Advanced Cardiovascular Systems, Inc.Ratcheting stentUS5458615Aug 6, 1993Oct 17, 1995Advanced Cardiovascular Systems, Inc.Stent delivery systemUS5474557Sep 16, 1994Dec 12, 1995Mai; ChristianMultibranch osteosynthesis clip with dynamic compression and self-retentionUS5507295Jun 29, 1993Apr 16, 1996British Technology Group LimitedMedical devicesUS5514161Apr 4, 1995May 7, 1996Ela Medical S.A.Methods and apparatus for controlling atrial stimulation in a double atrial triple chamber cardiac pacemakerUS5554177Mar 27, 1995Sep 10, 1996Medtronic, Inc.Method and apparatus to optimize pacing based on intensity of acoustic signalUS5562698Nov 8, 1994Oct 8, 1996Cook IncorporatedIntravascular treatment systemUS5584867Apr 4, 1995Dec 17, 1996Ela Medical S.A.Method and apparatus for controlling a double atrial triple chamber cardiac pacemaker having a fallback modeUS5601600Sep 8, 1995Feb 11, 1997Conceptus, Inc.Endoluminal coil delivery system having a mechanical release mechanismUS5676671Sep 3, 1996Oct 14, 1997Inoue; KanjiDevice for introducing an appliance to be implanted into a catheterUS5733325May 6, 1996Mar 31, 1998C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement systemUS5741297Aug 28, 1996Apr 21, 1998Simon; MorrisDaisy occluder and method for septal defect repairUS5752969Jun 16, 1994May 19, 1998Sofamor S.N.C.Instrument for the surgical treatment of an intervertebral disc by the anterior routeUS5800519Nov 4, 1996Sep 1, 1998Kopin CorporationTubular medical prosthesis for use in a body lumenUS5824071Feb 12, 1997Oct 20, 1998Circulation, Inc.Apparatus for treatment of ischemic heart disease by providing transvenous myocardial perfusionUS5836882Mar 17, 1997Nov 17, 1998Frazin; Leon J.Method and apparatus of localizing an insertion end of a probe within a biotic structureUS5871501Jan 12, 1998Feb 16, 1999Datascope Investment Corp.Guide wire with releasable barb anchorUS5891193Apr 11, 1997Apr 6, 1999C.R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system thereforUS5895391Sep 27, 1996Apr 20, 1999Target Therapeutics, Inc.Ball lock joint and introducer for vaso-occlusive memberUS5899882Apr 4, 1996May 4, 1999Novoste CorporationCatheter apparatus for radiation treatment of a desired area in the vascular system of a patientUS5908404Mar 3, 1998Jun 1, 1999Elliott; James B.Methods for inserting an implantUS5928258Sep 26, 1997Jul 27, 1999Corvita CorporationMethod and apparatus for loading a stent or stent-graft into a delivery sheathUS5935161Apr 11, 1997Aug 10, 1999C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system thereforUS5954761Mar 25, 1997Sep 21, 1999Intermedics Inc.Implantable endocardial lead assembly having a stentUS5961545Jan 17, 1997Oct 5, 1999Meadox Medicals, Inc.EPTFE graft-stent composite deviceUS5978705Mar 13, 1998Nov 2, 1999Uab Research FoundationMethod and apparatus for treating cardiac arrhythmia using auxiliary pulseUS5984944Feb 20, 1998Nov 16, 1999B. Braun Medical, Inc.Introducer for an expandable vascular occlusion deviceUS6007519Jul 30, 1997Dec 28, 1999Rosselli; MatteoCentral access cannulation deviceUS6015402Jun 4, 1998Jan 18, 2000Sahota; HarvinderWire perfusion catheterUS6022371Jul 21, 1998Feb 8, 2000Scimed Life Systems, Inc.Locking stentUS6027517May 13, 1997Feb 22, 2000Radiance Medical Systems, Inc.Fixed focal balloon for interactive angioplasty and stent implantation catheter with focalized balloonUS6053900Oct 7, 1998Apr 25, 2000Brown; Joe E.Apparatus and method for delivering diagnostic and therapeutic agents intravascularlyUS6077295Jul 15, 1996Jun 20, 2000Advanced Cardiovascular Systems, Inc.Self-expanding stent delivery systemUS6077297Jan 12, 1998Jun 20, 2000C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system thereforUS6080182Dec 19, 1997Jun 27, 2000Gore Enterprise Holdings, Inc.Self-expanding defect closure device and method of making and usingUS6096064Sep 19, 1997Aug 1, 2000Intermedics Inc.Four chamber pacer for dilated cardiomyopthyUS6099549Jun 11, 1999Aug 8, 2000Cordis CorporationVascular filter for controlled releaseUS6099552Nov 12, 1997Aug 8, 2000Boston Scientific CorporationGastrointestinal copression clipsUS6129755Jan 9, 1998Oct 10, 2000Nitinol Development CorporationIntravascular stent having an improved strut configurationUS6171320Oct 7, 1997Jan 9, 2001Niti Alloys Technologies Ltd.Surgical clipUS6183512Apr 16, 1999Feb 6, 2001Edwards Lifesciences CorporationFlexible annuloplasty systemUS6190406Feb 2, 1999Feb 20, 2001Nitinal Development CorporationIntravascular stent having tapered strutsUS6210432Jun 30, 1999Apr 3, 2001Jan Otto SolemDevice and method for treatment of mitral insufficiencyUS6228098Jul 10, 1998May 8, 2001General Surgical Innovations, Inc.Apparatus and method for surgical fasteningUS6241757Feb 3, 1998Jun 5, 2001Solco Surgical Instrument Co., Ltd.Stent for expanding body's lumenUS6254628Dec 9, 1996Jul 3, 2001Micro Therapeutics, Inc.Intracranial stentUS6267783Jul 27, 2000Jul 31, 2001Cordis CorporationStent which is easily recaptured and repositioned within the bodyUS6275730Sep 7, 1999Aug 14, 2001Uab Research FoundationMethod and apparatus for treating cardiac arrythmiaUS6312446Sep 12, 2000Nov 6, 2001Scimed Life Systems, Inc.Apparatus and method for closing a septal defectUS6334864May 17, 2000Jan 1, 2002Aga Medical Corp.Alignment member for delivering a non-symmetric device with a predefined orientationUS6342067Jan 9, 1998Jan 29, 2002Nitinol Development CorporationIntravascular stent having curved bridges for connecting adjacent hoopsUS6345198Jul 29, 1999Feb 5, 2002Pacesetter, Inc.Implantable stimulation system for providing dual bipolar sensing using an electrode positioned in proximity to the tricuspid valve and programmable polarityUS6352553Jul 18, 1997Mar 5, 2002Gore Enterprise Holdings, Inc.Stent-graft deployment apparatus and methodUS6352561Dec 23, 1996Mar 5, 2002W. L. Gore & AssociatesImplant deployment apparatusUS6358195Mar 9, 2000Mar 19, 2002Neoseed Technology LlcMethod and apparatus for loading radioactive seeds into brachytherapy needlesUS6395017Nov 15, 1996May 28, 2002C. R. Bard, Inc.Endoprosthesis delivery catheter with sequential stage controlUS6402781 *Jan 31, 2000Jun 11, 2002MitralifePercutaneous mitral annuloplasty and cardiac reinforcementUS6419696Jul 6, 2000Jul 16, 2002Paul A. SpenceAnnuloplasty devices and related heart valve repair methodsUS6442427Apr 27, 2000Aug 27, 2002Medtronic, Inc.Method and system for stimulating a mammalian heartUS6503271Dec 7, 2000Jan 7, 2003Cordis CorporationIntravascular device with improved radiopacityUS6537314Jan 30, 2001Mar 25, 2003Ev3 Santa Rosa, Inc.Percutaneous mitral annuloplasty and cardiac reinforcementUS6562067Jun 8, 2001May 13, 2003Cordis CorporationStent with interlocking elementsUS6569198Mar 30, 2001May 27, 2003Richard A. WilsonMitral or tricuspid valve annuloplasty prosthetic deviceUS6589208May 30, 2001Jul 8, 2003Applied Medical Resources CorporationSelf-deploying catheter assemblyUS6599314Jun 8, 2001Jul 29, 2003Cordis CorporationApparatus and method for stenting a vessel using balloon-actuated stent with interlocking elementsUS6602288Oct 5, 2000Aug 5, 2003Edwards Lifesciences CorporationMinimally-invasive annuloplasty repair segment delivery template, system and method of useUS6602289Jun 8, 1999Aug 5, 2003S&A Rings, LlcAnnuloplasty rings of particular use in surgery for the mitral valveUS6623521Dec 14, 2000Sep 23, 2003Md3, Inc.Expandable stent with sliding and locking radial elementsUS6626899Jul 3, 2001Sep 30, 2003Nidus Medical, LlcApparatus and methods for treating tissueUS6629534Apr 7, 2000Oct 7, 2003Evalve, Inc.Methods and apparatus for cardiac valve repairUS6629994Jun 11, 2001Oct 7, 2003Advanced Cardiovascular Systems, Inc.Intravascular stentUS6643546Feb 13, 2002Nov 4, 2003Quetzal Biomedical, Inc.Multi-electrode apparatus and method for treatment of congestive heart failureUS6648881Aug 27, 2001Nov 18, 2003Cardiac Pacemakers, Inc.Method for reducing arterial restenosis in the presence of an intravascular stentUS6652538May 8, 2001Nov 25, 2003General Surgical Innovations, Inc.Apparatus and method for surgical fasteningUS6656221Feb 5, 2002Dec 2, 2003Viacor, Inc.Method and apparatus for improving mitral valve functionUS6676702May 14, 2001Jan 13, 2004Cardiac Dimensions, Inc.Mitral valve therapy assembly and methodUS6709425Jan 31, 2001Mar 23, 2004C. R. Bard, Inc.Vascular inducing implantsUS6716158Sep 6, 2002Apr 6, 2004Mardil, Inc.Method and apparatus for external stabilization of the heartUS6718985May 25, 2001Apr 13, 2004Edwin J. HlavkaMethod and apparatus for catheter-based annuloplasty using local plicationsUS6721598Aug 31, 2001Apr 13, 2004Pacesetter, Inc.Coronary sinus cardiac lead for stimulating and sensing in the right and left heart and systemUS6723038Oct 6, 2000Apr 20, 2004Myocor, Inc.Methods and devices for improving mitral valve functionUS6733521Apr 11, 2001May 11, 2004Trivascular, Inc.Delivery system and method for endovascular graftUS6743219Aug 2, 2000Jun 1, 2004Cordis CorporationDelivery apparatus for a self-expanding stentUS6764510Jan 9, 2002Jul 20, 2004Myocor, Inc.Devices and methods for heart valve treatmentUS6773446Aug 2, 2000Aug 10, 2004Cordis CorporationDelivery apparatus for a self-expanding stent* Cited by examinerNon-Patent CitationsReference1Gordon et al.; U.S. Appl. No. 11/971,174 entitled "Medical device delivery system," filed Jan. 8, 2008.2Gray, H. Anatomy of the Human Body. The Systemic Veins. Philadelphia: Lea & Febiger, 1918; Bartleby.com. 2000. Available at www.bartleby.com/107/. Accessed Jun. 7, 2006.3Heartsite.com. Echocardiogram, 1999; p. 1-4. A.S.M. Systems Inc. Available at: http://www.heartsite.com/html/echocardiogram.html. Accessed Jul. 1, 2005.4Mathis et al., U.S. Appl. No. 11/782,490 entitled "Device and method for modifying the shape of a body organ," filed Jul. 24, 2007.5Mathis et al., U.S. Appl. No. 11/782,508, entitled "Device and method for modifying the shape of a body organ," filed Jul. 24, 2007.6Mathis et al., U.S. Appl. No. 11/782,527 entitled "Device and method for modifying the shape of a body organ," filed Jul. 24, 2007.7Mathis et al.; U.S. Appl. No. 12/016,054 entitled "Fixed anchor and pull mitral valve device and method," filed Jan. 17, 2008.8Mathis et al; U.S. Appl. No. 11/963,417 entitled "Device and method for modifying the shape of a body organ," filed Dec. 21, 2007.9Mathis, et al; U.S. Appl. No. 11/279,352, entitled "Mitral Valve Annuloplasty Device with Vena Cava Anchor," filed Apr. 11, 2006.10Mathis, Mark; U.S. Appl. No. 11/655,710, entitled "Mitral Valve Device Using Conditioned Shape Memory Alloy," filed Jan. 18, 2007.11Nieminen et al; U.S. Appl. No. 12/060,781 entitled "Tissue shaping device," filed Apr. 1, 2008.12Pai, Suresh; U.S. Appl. No. 60/329,694 entitled "Percutaneous cardiac support structures and deployment means," filed Oct. 16, 2001.13Papageorgiou, P., et al., "Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation," Circulation 96: 1893-1898, Sep. 16, 1977.Referenced byCiting PatentFiling datePublication dateApplicantTitleUS8142455Sep 12, 2008Mar 27, 2012Pneumrx, Inc.Delivery of minimally invasive lung volume reduction devicesUS8157823Sep 12, 2008Apr 17, 2012Pneumrx, Inc.Lung volume reduction devices, methods, and systemsUS8157837Jun 2, 2006Apr 17, 2012Pneumrx, Inc.Minimally invasive lung volume reduction device and methodUS8250960Aug 29, 2011Aug 28, 2012Cardiac Dimensions, Inc.Catheter cutting toolUS8282660Jul 2, 2008Oct 9, 2012Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systemsUS8632605Sep 11, 2009Jan 21, 2014Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systemsUS8668707Sep 14, 2012Mar 11, 2014Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systemsUS8721734May 18, 2010May 13, 2014Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction deviceUS8740921Sep 14, 2012Jun 3, 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systemsUS8888800Mar 13, 2012Nov 18, 2014Pneumrx, Inc.Lung volume reduction devices, methods, and systemsUS8932310Sep 14, 2012Jan 13, 2015Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systemsUS8961596 *Jul 21, 2011Feb 24, 20154Tech Inc.Method and apparatus for tricuspid valve repair using tensionUS8974525Oct 19, 2010Mar 10, 2015Cardiac Dimensions Pty. Ltd.Tissue shaping deviceUS9078749Aug 21, 2014Jul 14, 2015Georg LutterTruncated cone heart valve stentUS9095433Oct 18, 2011Aug 4, 2015Georg LutterTruncated cone heart valve stentUS9173669Sep 11, 2009Nov 3, 2015Pneumrx, Inc.Enhanced efficacy lung volume reduction devices, methods, and systemsUS9192403Dec 19, 2013Nov 24, 2015Pneumrx, Inc.Elongated lung volume reduction devices, methods, and systemsUS9241702Jul 19, 2012Jan 26, 20164Tech Inc.Method and apparatus for tricuspid valve repair using tensionUS9254192Jun 22, 2015Feb 9, 2016Georg LutterTruncated cone heart valve stentUS9307980Dec 30, 2013Apr 12, 20164Tech Inc.Tricuspid valve repair using tensionUS9320600Mar 9, 2015Apr 26, 2016Cardiac Dimensions Pty. Ltd.Tissue shaping deviceUS9402632Apr 24, 2014Aug 2, 2016Pneumrx, Inc.Lung volume reduction devices, methods, and systemsUS9402633Mar 13, 2014Aug 2, 2016Pneumrx, Inc.Torque alleviating intra-airway lung volume reduction compressive implant structuresUS9402971Jan 23, 2014Aug 2, 2016Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systemsUS9474533Mar 26, 2014Oct 25, 2016Pneumrx, Inc.Cross-sectional modification during deployment of an elongate lung volume reduction deviceUS9480559Aug 13, 2012Nov 1, 2016Tendyne Holdings, Inc.Prosthetic valves and related inventionsUS9486306Jan 14, 2014Nov 8, 2016Tendyne Holdings, Inc.Inflatable annular sealing device for prosthetic mitral valveUS9526611Oct 29, 2014Dec 27, 2016Tendyne Holdings, Inc.Apparatus and methods for delivery of transcatheter prosthetic valvesUS9539670 *May 24, 2011Jan 10, 2017Creganna-Tactx MedicalJoint for tubular materialsUS20070221230 *Jun 2, 2006Sep 27, 2007David ThompsonMinimally invasive lung volume reduction device and methodUS20090012626 *Jul 2, 2008Jan 8, 2009Pneumrx, Inc.Minimally invasive lung volume reduction devices, methods, and systemsUS20090076622 *Sep 12, 2008Mar 19, 2009Pneumrx, Inc.Delivery of Minimally Invasive Lung Volume Reduction DevicesUS20090076623 *Sep 12, 2008Mar 19, 2009Pneumrx, Inc.Lung Volume Reduction Devices, Methods, and SystemsUS20090082619 *Dec 2, 2008Mar 26, 2009De Marchena EduardoMethod of treating cardiomyopathyUS20100185278 *Jan 21, 2010Jul 22, 2010Tendyne MedicalApical Papillary Msucle Attachment for Left Ventricular ReductionUS20100210899 *Mar 29, 2010Aug 19, 2010Tendyne Medical, Inc.Method for percutaneous lateral access to the left ventricle for treatment of mitral insufficiency by papillary muscle alignmentUS20100280602 *Jul 16, 2010Nov 4, 2010Cardiac Dimensions, Inc.Mitral Valve Device Using Conditioned Shape Memory AlloyUS20100305715 *May 18, 2010Dec 2, 2010Pneumrx, Inc.Cross-Sectional Modification During Deployment of an Elongate Lung Volume Reduction DeviceUS20110004296 *Sep 10, 2008Jan 6, 2011Georg LutterHeart Valve StentUS20110015476 *Oct 14, 2009Jan 20, 2011Jeff FrancoDevices and Methods for Treating CardiomyopathyUS20110035000 *Oct 19, 2010Feb 10, 2011Cardiac Dimensions, Inc.Tissue Shaping DeviceUS20110066234 *Nov 22, 2010Mar 17, 2011Gordon Lucas SPercutaneous Mitral Valve Annuloplasty Delivery SystemUS20110291407 *May 24, 2011Dec 1, 2011Mcdermott BernardJoint for tubular materialsUS20120035712 *Jul 21, 2011Feb 9, 2012Francesco MaisanoMethod and apparatus for tricuspid valve repair using tension* Cited by examinerClassifications U.S. Classification623/2.36, 623/2.37International ClassificationA61F2/24Cooperative ClassificationA61F2/2451European ClassificationA61F2/24R4Legal EventsDateCodeEventDescriptionApr 17, 2007ASAssignmentOwner name: CARDIAC DIMENSIONS, INC., WASHINGTONFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KOWALSKY, LEONARD;NIEMINEN, GREGORY D.;BRAXTAN, RYAN H.;AND OTHERS;REEL/FRAME:019179/0967;SIGNING DATES FROM 20040626 TO 20040714Aug 29, 2012FPAYFee paymentYear of fee payment: 4Apr 24, 2014ASAssignmentOwner name: CARDIAC DIMENSIONS PTY. LTD., WASHINGTONFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARDIAC DIMENSIONS, INC.;REEL/FRAME:032759/0069Effective date: 20140411Sep 1, 2016FPAYFee paymentYear of fee payment: 8RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services